Norgestimate/Ethinyl Estradiol Tablets
This appears to be an award/contract entry for norgestimate/ethinyl estradiol tablets under a specific procurement number. It does not describe an open funding program or new application opportunity; it likely reflects completed award activity for pharmaceutical supply or product delivery rather than research grant funding.
Keywords
Supporting Links
Documents
Similar Opportunities
-
Biological Testing Facility for Contraception & Reproductive Health (X01 Clinical Trial Not Allowed)
National Institutes of Health
-
Anastrozole - Award
Defense Logistics Agency
-
Mood and Psychosis Symptoms during the Menopause Transition (R21 Clinical Trial Optional)
National Institutes of Health
-
Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional)
National Institutes of Health
-
National CMOP ARTIFICIAL SALIVA ORAL SPRAY
Department of Veterans Affairs
Find tens of thousands more opportunities — free
Scout accounts are free. Sign up to browse the full funding database, unlock the solicitation links and documents for this opportunity, and see how well each one fits your organization.
-
Tens of thousands of funding opportunities
Search and filter every grant and solicitation in Scout — all free, no credit card required.
-
Instant Fit Analysis
Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
-
Source links & full documents
Jump straight to the solicitation and download every attachment.
-
Save opportunities & track deadlines
Keep the opportunities that fit in one place and stay ahead of every due date.
Already have an account? Sign In
Trusted by 500+ Happy Customers